Unknown

Dataset Information

Soluble CD93 in Serum as a Marker of Allergic Inflammation.


ABSTRACT:

Purpose

CD93 is receiving renewed attention as a biomarker of inflammation. We aimed to evaluate the potential for serum sCD93 to serve as a novel biomarker for allergic inflammation.

Materials and methods

We enrolled 348 subjects with an allergic disease [allergic rhinitis (AR), chronic spontaneous urticaria (CSU), or bronchial asthma (BA)], including 14 steroid-naïve BA patients who were serially followed-up.

Results

The serum sCD93 levels (ng/mL) in patients with exacerbated AR (mean±standard deviation, 153.1±58.4) were significantly higher than in patients without AR (132.2±49.0) or with stable AR (122.3±42.1). Serum sCD93 levels in exacerbated CSU (169.5±42.8) were also significantly higher than those in non-CSU (132.4±51.6) and stable CSU (122.8±36.2). This tren

SUBMITTER: Park HJ 

PROVIDER: S-EPMC5368146 | biostudies-literature | 2017 May

REPOSITORIES: biostudies-literature